As one of the four “persistent diseases” in ancient China, stroke is also one of the “four high” diseases with “high incidence, high recurrence, high disability and high death rate” in today’s society. The four highs basically encompass the characteristics of the disease. Stroke has become the first cause of disability and death in China’s urban and rural population, and the incidence of ischemic stroke, the main type of stroke, has been increasing year by year. There are more than 7 million patients with cerebrovascular disease in China, of which about 70% are ischemic strokes. The annual cost of treating stroke is estimated to be more than 10 billion RMB, and with various indirect economic losses, the annual expenditure due to this disease is close to 20 billion RMB, causing a heavy economic burden to the country and many families. The first and foremost concern of many patients is “Can stroke be cured?” This is a very important and practical question, but it is not very “objective”. Therefore, it is necessary to understand the treatment options for stroke. At present, there are several effective means recognized worldwide for the treatment of stroke (this article is limited to ischemic stroke, because it accounts for about 70% of stroke, i.e. cerebral infarction, cerebral infarction): 1. r-tpa thrombolysis within the time window (within 4.5 hours of onset), because the time requirement is relatively strict, according to some scholars, less than 1% of patients in China can receive this treatment within the time window, and the biggest risk of thrombolysis is bleeding; 2. The biggest risk is bleeding; 2. Stroke unit, a system to improve the medical management model and outcome of hospitalized stroke patients, provides medication, physical rehabilitation, language training, psychological rehabilitation and health education for stroke patients. The core staff of the stroke unit includes clinicians, specialized nurses, physiotherapists, occupational therapists, speech trainers and social workers. Simply put, it is comprehensive management, and it is not a one-shot solution; 3. Anti-platelet aggregation therapy, which is commonly known as oral aspirin, but this treatment is mainly secondary prevention, which means reducing the risk of reoccurrence of stroke; 4. Atrial fibrillation Patients undergo antiaggregation therapy, which is often referred to as oral warfarin. Of course, the above treatment is the general treatment principle, which is the international “guideline” that everyone basically agrees. However, it can be said that stroke is not a single disease, it can be the final result of multiple diseases, such as atrial fibrillation, hypertension, diabetes, etc. are common risk factors for stroke disease. Well, to answer the question again, can stroke disease be cured? If the stroke site is in a relatively “quiet area”, that is to say, not very important area, and the scope is small, the chance of cure for such a stroke patient is very high; however, if the stroke site is more important, though small, for example, in the brainstem (human whistling, heartbeat and other high centers), then the chance of cure is relatively high. The difficulty is relatively greater, but not without chance; furthermore, if it is a large blood vessel stenosis, causing a large cerebral infarction, it is quite difficult to recover to the state before the onset of the disease.